Global Fetal Bovine Serum (FBS) for Cell Culture Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Fetal Bovine Serum (FBS) for Cell Culture market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Fetal Bovine Serum (FBS) is a widely-used growth supplement for cell culture media that provides many defined and undefined components that have been shown to satisfy specific metabolic requirements for the culture of cells.
Fetal bovine serum is the remained blood fraction after the natural coagulation of blood, which is obtained by centrifugation to remove any remaining red blood cells. Fetal bovine serum has been irreplaceable media in cell culture industry. The raw material of fetal bovine serum is fetal bovine blood. The FBS suppliers make contract with beef processer or agent and gather fetal bovine blood at certain time. The production of FBS is quite seasonal because the raw material source can only be acquired twice a year. The primary factor and main market-driver is the beef processing industry, since FBS is produced as a byproduct of this industry.
The manufacturers of FBS are concentrated in North America, Australia, New Zealand and South America. The growth of FBS production has been modest for the past years, due to the deficiency of raw material supply. The primary application of FBS is to fortify cell culture media. It is the most common media supplement used for cell culture.
This report is a detailed and comprehensive analysis for global Fetal Bovine Serum (FBS) for Cell Culture market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Fetal Bovine Serum (FBS) for Cell Culture market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Fetal Bovine Serum (FBS) for Cell Culture market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Fetal Bovine Serum (FBS) for Cell Culture market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Fetal Bovine Serum (FBS) for Cell Culture market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fetal Bovine Serum (FBS) for Cell Culture
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fetal Bovine Serum (FBS) for Cell Culture market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Merck, Cytiva, Biowest, Moregate BioTech, ExCell Bio, Internegocios, Tissue Culture Biologicals, Gemini, Corning, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Fetal Bovine Serum (FBS) for Cell Culture market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
USA-sourced
South America-sourced
Australia-sourced
Others
Market segment by Application
Scientific Research
Industrial Production
Major players covered
Thermo Fisher
Merck
Cytiva
Biowest
Moregate BioTech
ExCell Bio
Internegocios
Tissue Culture Biologicals
Gemini
Corning
Biological Industries
VWR
Bovogen
R&D Systems
Seroxlab
Animal Technologies
RMBIO
Bio Nutrientes Brasil
Serana
WISENT
PAN-Biotech
Zhejiang Tianhang Biotechnology
Lanzhou Minhai
Peak Serum
Jin Yuan Kang
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fetal Bovine Serum (FBS) for Cell Culture product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fetal Bovine Serum (FBS) for Cell Culture, with price, sales quantity, revenue, and global market share of Fetal Bovine Serum (FBS) for Cell Culture from 2020 to 2025.
Chapter 3, the Fetal Bovine Serum (FBS) for Cell Culture competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fetal Bovine Serum (FBS) for Cell Culture breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Fetal Bovine Serum (FBS) for Cell Culture market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fetal Bovine Serum (FBS) for Cell Culture.
Chapter 14 and 15, to describe Fetal Bovine Serum (FBS) for Cell Culture sales channel, distributors, customers, research findings and conclusion.
Fetal Bovine Serum (FBS) is a widely-used growth supplement for cell culture media that provides many defined and undefined components that have been shown to satisfy specific metabolic requirements for the culture of cells.
Fetal bovine serum is the remained blood fraction after the natural coagulation of blood, which is obtained by centrifugation to remove any remaining red blood cells. Fetal bovine serum has been irreplaceable media in cell culture industry. The raw material of fetal bovine serum is fetal bovine blood. The FBS suppliers make contract with beef processer or agent and gather fetal bovine blood at certain time. The production of FBS is quite seasonal because the raw material source can only be acquired twice a year. The primary factor and main market-driver is the beef processing industry, since FBS is produced as a byproduct of this industry.
The manufacturers of FBS are concentrated in North America, Australia, New Zealand and South America. The growth of FBS production has been modest for the past years, due to the deficiency of raw material supply. The primary application of FBS is to fortify cell culture media. It is the most common media supplement used for cell culture.
This report is a detailed and comprehensive analysis for global Fetal Bovine Serum (FBS) for Cell Culture market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Fetal Bovine Serum (FBS) for Cell Culture market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Fetal Bovine Serum (FBS) for Cell Culture market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Fetal Bovine Serum (FBS) for Cell Culture market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Fetal Bovine Serum (FBS) for Cell Culture market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fetal Bovine Serum (FBS) for Cell Culture
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fetal Bovine Serum (FBS) for Cell Culture market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Merck, Cytiva, Biowest, Moregate BioTech, ExCell Bio, Internegocios, Tissue Culture Biologicals, Gemini, Corning, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Fetal Bovine Serum (FBS) for Cell Culture market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
USA-sourced
South America-sourced
Australia-sourced
Others
Market segment by Application
Scientific Research
Industrial Production
Major players covered
Thermo Fisher
Merck
Cytiva
Biowest
Moregate BioTech
ExCell Bio
Internegocios
Tissue Culture Biologicals
Gemini
Corning
Biological Industries
VWR
Bovogen
R&D Systems
Seroxlab
Animal Technologies
RMBIO
Bio Nutrientes Brasil
Serana
WISENT
PAN-Biotech
Zhejiang Tianhang Biotechnology
Lanzhou Minhai
Peak Serum
Jin Yuan Kang
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fetal Bovine Serum (FBS) for Cell Culture product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fetal Bovine Serum (FBS) for Cell Culture, with price, sales quantity, revenue, and global market share of Fetal Bovine Serum (FBS) for Cell Culture from 2020 to 2025.
Chapter 3, the Fetal Bovine Serum (FBS) for Cell Culture competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fetal Bovine Serum (FBS) for Cell Culture breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Fetal Bovine Serum (FBS) for Cell Culture market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fetal Bovine Serum (FBS) for Cell Culture.
Chapter 14 and 15, to describe Fetal Bovine Serum (FBS) for Cell Culture sales channel, distributors, customers, research findings and conclusion.
Table of Contents
152 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Fetal Bovine Serum (FBS) for Cell Culture by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
